i
Human papillomavirus vaccination among adults aged 18−26, 2013−2018
-
January 2020
-
[PDF-445.92 KB]
Details:
-
Personal Author:
-
Corporate Authors:
-
Description:Key findings
Data from the National Health Interview Survey
• Among adults aged 18−26, the percentage who ever received one or more doses of human papillomavirus (HPV) vaccine increased from 22.1% in 2013 to 39.9% in 2018.
• The percentage of adults aged 18−26 who received the recommended number of doses of HPV vaccine increased from 13.8% in 2013 to 21.5% in 2018.
• In 2018, non-Hispanic white adults were more likely than Hispanic adults to have ever received one or more doses of HPV vaccine.
• Among adults aged 18−26 who ever received one or more doses of HPV vaccine, the majority received the first dose between the ages of 13 and 17 years.
Human papillomavirus (HPV) is a sexually transmitted infection common among both men and women (1). HPV vaccination, which requires multiple doses, was first recommended for girls in 2006 and for boys in 2011 (2,3). Vaccination is routinely recommended at 11−12 years and can be started at age 9 (4). For those not vaccinated at 11−12 years, vaccination is recommended for all persons through age 26 years (4). Two HPV vaccine doses, given 6 to 12 months apart, are recommended if the series is started before age 15. Three doses, to be completed within 6 months, are recommended for those who started vaccination at age 15 or over (4,5). This report describes trends in self-reported HPV vaccination initiation and completion by selected demographic characteristics among adults aged 18−26.
Suggested citation: Boersma P, Black LI. Human papillomavirus vaccination among adults aged 18−26, 2013−2018. NCHS Data Brief, no 354. Hyattsville, MD: National Center for Health Statistics. 2020.
CS313615
db354-h.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Place as Subject:
-
Pages in Document:7 numbered pages
-
Issue:354
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
